Efficacy of adding levofoxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patients with advanced pancreatic cancer: Study protocol for a multicenter, randomized phase 2 trial (T-CORE2201)
Số trang: 8
Loại file: pdf
Dung lượng: 1.66 MB
Lượt xem: 7
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
Advanced pancreatic cancer is one of the leading causes of cancer-related deaths. This prospective study aims to evaluate whether the addition of antibiotics improves the treatment efficacy of GEM/nabPTX as a first-line chemotherapy in patients with advanced pancreatic cancer.
Nội dung trích xuất từ tài liệu:
Efficacy of adding levofoxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patients with advanced pancreatic cancer: Study protocol for a multicenter, randomized phase 2 trial (T-CORE2201)
Nội dung trích xuất từ tài liệu:
Efficacy of adding levofoxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patients with advanced pancreatic cancer: Study protocol for a multicenter, randomized phase 2 trial (T-CORE2201)
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Pancreatic cancer Multicenter randomized phase 2 study Nanoparticle albumin binding paclitaxel Median progression Free survival timeTài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 173 0 0 -
6 trang 167 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 144 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 121 0 0 -
12 trang 94 0 0
-
19 trang 75 0 0
-
17 trang 65 0 0
-
9 trang 45 0 0
-
12 trang 39 0 0
-
Investigating the prognostic and predictive value of the type II cystatin genes in gastric cancer
17 trang 38 0 0